Medical Laboratory Services In Ghana: Challenges, Corruption Allegations, And The Medical “kalabule” Debate

Medical laboratory services are essential to Ghana’s healthcare delivery system. Medical laboratories provide critical diagnostic services in areas including medical microbiology, clinical chemistry, haematology, immunology and serology, histopathology and cytology, and disease surveillance. These services inform clinical decision-making, treatment planning, and public health interventions. Public facilities such as teaching hospitals, regional hospitals, and district hospitals alongside private laboratories, contribute to the country’s diagnostic landscape. The sector is regulated by the Allied Health Professions Council, with professional bodies such as the Ghana Association of Medical Laboratory Scientists (GAMLS) playing an important role in promoting ethical standards and professional conduct to ensure patient safety.

Despite the important role medical laboratories play in healthcare delivery and disease surveillance, the sector faces significant infrastructural, human resource, and logistical challenges that undermine the effectiveness of laboratory services. Many healthcare facilities lack functional medical laboratory services, compelling clinicians to manage patients with limited empirical laboratory evidence. Resource constraints, including frequent stock-outs of reagents and malfunctioning or unavailable equipment, further affect the capacity to conduct critical diagnostic tests. Additional challenges include workforce shortages and inadequate deployment in public facilities, largely due to a freeze on public sector employment, which has left many qualified medical laboratory scientists unemployed since 2019 despite an evident national need for their services. The proliferation of unstandardized training institutions and the growth of private laboratories with questionable quality assurance and oversight remain problematic, particularly as regulation of the sector remains weak. These conditions can erode patient trust and create gaps that private providers and opportunistic actors may exploit.

Public laboratories, including central laboratories in teaching hospitals, have repeatedly cautioned clinicians and staff against referring patients directly to private laboratories for diagnostic tests that can and should be performed in-house. Standard practice in medical laboratory referrals requires that management approves referral systems based on recognized and documented quality assessments. This approach minimizes partiality and corruption that could compromise patient safety. The Central Laboratory at Korle Bu Teaching Hospital, for example, has appealed to hospital staff to route laboratory requests through proper internal referral systems to ensure quality assurance, accountability, and cost containment for patients. As a follow-up, hospital management, through the Chief Executive Officer, has widely communicated to the general public the need to ensure that services available within the hospital are not unnecessarily outsourced. This arrangement is line with clause 4.1 of the ISO 15189:2022 that requires that practices that introduce partiality in medical laboratory practice are identified and eliminated including ownership, marketing, branding, referral and procurement fraud among many others.

However, despite the availability of capacity in many public health facilities, it remains common for physicians and clinicians to issue laboratory test requests or prescriptions that direct patients to private facilities located near public hospitals. This practice is driven by perceived or real gaps in public laboratory capacity, such as frequent reagent stock-outs and slow turnaround times. Patients’ perceptions that private laboratories provide “better” or “faster” services also contribute. In some cases, financial incentives or informal arrangements encourage providers to direct patients to specific private entities. When unregulated, these practices raise serious ethical concerns regarding conflicts of interest and patient exploitation. Allegations of unscrupulous behaviour such as deliberately creating service gaps to boost referrals to private facilities have become widespread narratives about corruption in Ghana’s health sector, including specific claims involving medical professionals.

In January 2026, an investigative report and documentary titled Medical Kalabule by The Fourth Estate sparked a national debate by alleging systematic exploitation of patients in public health facilities, particularly at the Greater Accra Regional Hospital (Ridge Hospital). The documentary focused on several troubling themes, beginning with alleged exploitation through referrals. It alleged that doctors at Ridge Hospital issued specialized request forms on private pharmacy stationery, directing patients to Axis Pharmacy for surgical supplies and consumables that should ordinarily have been procured through the hospital’s internal systems. In some instances, patients were reportedly charged exorbitant amounts sometimes in foreign currency for items that may already have been available within the public facility.

A second theme highlighted by the investigation was inflated and opaque billing practices by health professionals. The Fourth Estate documented cases in which patients were charged thousands of dollars for items such as neuronavigation systems and surgical components. The findings suggested pricing inconsistencies for the same equipment and a lack of transparency regarding what was actually supplied versus what was billed.

These revelations have provoked public outrage and intensified concerns about what critics describe as “kalabule” ;illicit, informal, and exploitative practices within health institutions that push patients into expensive private transactions. The documentary exposed what it portrayed as hidden realities within the health delivery system, where some individuals allegedly amass wealth for personal gain at the expense of patients.

The Medical Kalabule debate raises several professional and ethical issues. Health professionals, including physicians, are ethically obligated to order investigations and make referrals that protect patients’ best interests, ensure quality care, and uphold institutional integrity. When clinicians refer patients directly to external private laboratories or issue non-standard prescriptions for commodities instead of using official hospital procurement channels, serious concerns arise regarding conflicts of interest and profiteering.

In several documented cases, surgeons were allegedly reported to have used private pharmacy requisition pads, potentially creating opportunities for personal or third-party financial gain at patients’ expense. Regulatory bodies such as the Allied Health Professions Council have taken actions against unlicensed or substandard laboratories and practitioners, underscoring the importance of professional licensure, quality assurance, and accountability in diagnostic services.

At the same time, the Medical Laboratory Professional Workers Union has resisted proposals perceived as undermining public laboratory functions, such as outsourcing or privatization. The Union argues that privatization, when presented as efficiency-driven reform, could in practice increase corruption and impose higher cost burdens on patients. Persistent corruption within medical supply chains where some suppliers allegedly use financial inducements to evade accountability remains a major challenge in many health facilities. Equally troubling is the politicization of medical supply contracts for alleged financial gain. These developments pose serious threats to sustainable medical laboratory services and patient safety, particularly when personal benefit is prioritized over the public good.

While the Medical Kalabule investigation presents a stark portrayal of unethical conduct, some analysts caution against oversimplifying the issue as solely a matter of individual corruption. They emphasize that Ghana’s public health system has long struggled with procurement bottlenecks, supply-chain inefficiencies, and administrative weaknesses that predate the current controversy. In some cases, questionable practices may reflect systemic failures rather than deliberate malice, blurring the line between survival strategies by underpaid professionals and outright misconduct.

Indeed, some assessments circulating in public discourse argue that direct evidence linking specific individuals to personal enrichment remains limited, and that structural weaknesses are significant drivers of the observed behaviors. Nevertheless, for many Ghanaians, the repeated experience of being directed to pay private entities for services that should be available within public hospitals feels like a breach of trust and professional duty.

The Medical Kalabule episode has brought medical laboratory services and broader health sector ethics into sharp national focus. It underscores the urgent need for stronger oversight and enforcement of referral practices to protect patients from exploitation. Clear auditing and procurement systems are needed to prevent the circumvention of institutional processes. Enhanced regulatory enforcement for both public and private laboratories is also essential to maintain quality and professional standards. We need to boldly question the physicians who continue to refer medical laboratory test to private laboratories for personal gain.

There is also an urgent need to improve support and remuneration for healthcare workers, addressing pressures that may drive some to seek alternative income sources. Ultimately, restoring trust in Ghana’s healthcare system will require structural reforms, rigorous accountability mechanisms, and a renewed commitment to public service ethics ensuring that medical laboratories and their professionals serve patients first, not profit. The Medical Kalabule documentary suggests that ongoing accusations against medical laboratories and medical laboratory scientists may not fully reflect reality when those making the requests prioritize personal gain over patient welfare.

By: Dr. Solomon D.Y. Kwashie, Medical Laboratory Scientists

[email protected]